TickerFacts.

Rein Therapeutics, Inc. (RNTX): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

Older than the company's other figures. The latest Free Cash Flow is for the year ended 2021-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Capital Expenditures, which Free Cash Flow is computed from, under the concepts TickerFacts maps.

-$23.91M
Year ended 2021-12-31
2015-12-31: -$11.80M2017-12-31: -$20.67M2018-12-31: -$32.35M2019-12-31: -$26.62M2020-12-31: -$20.48M2021-12-31: -$23.91M-$23.91M
2015-12-31 Free Cash Flow (USD) 2021-12-31
Period endedFree Cash FlowChange YoYSource filing
2021-12-31-$23.91Mn/m2023-03-20, From 2021-01-01
2020-12-31-$20.48Mn/m2022-03-28, From 2020-01-01
2019-12-31-$26.62Mn/m2021-03-24, From 2019-01-01
2018-12-31-$32.35Mn/m2020-03-30, From 2018-01-01
2017-12-31-$20.67Mn/a2019-03-29, From 2017-01-01
No annual figure between 2015-12-31 and 2017-12-31.
2015-12-31-$11.80Mn/a2018-04-02, From 2015-01-01